Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice
Open Access
- 11 June 2020
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 8 (6) , 157
Abstract
Several cell populations derived from bone marrow (BM) have been shown to possess cardiac regenerative potential. Among these are freshly isolated CD133+ hematopoietic as well as culture-expanded mesenchymal stem cells. Alternatively, by purifying CD271+ cells from BM, mesenchymal progenitors can be enriched without an ex vivo cultivation. With regard to the limited available number of freshly isolated BM-derived stem cells, the effect of the dosage on the therapeutic efficiency is of particular interest. Therefore, in the present pre-clinical study, we investigated human BM-derived CD133+ and CD271+ stem cells for their cardiac regenerative potential three weeks post-myocardial infarction (MI) in a dose-dependent manner. The improvement of the hemodynamic function as well as cardiac remodeling showed no therapeutic difference after the transplantation of both 100,000 and 500,000 stem cells. Therefore, beneficial stem cell transplantation post-MI is widely independent of the cell dose and detrimental stem cell amplification in vitro can likely be avoided.Keywords
Funding Information
- Massachusetts Department of Fish and Game (DA1296/6-1)
- Deutsche Herzstiftung (F/01/12)
- Federal Ministry of Education and Research Germany (FKZ 0312138A, FKZ 316159)
- EU Structural Funds (ESF/IVWM-B34-0030/10, ESF/IVBM-B35-0010/12, ESF/14-BM-A55-0024/18)
- FORUN Program of Rostock University Medical Centre (889001, 889003, 889036)
- Josef and Käthe Klinz foundation (T319/29737/2017)
- DAMP Foundation and the BMBF (VIP+ 00240)
This publication has 42 references indexed in Scilit:
- Mesenchymal Cell Contributions to the Stem Cell NicheCell Stem Cell, 2015
- Stem cell therapy for cardiac dysfunctionSpringerPlus, 2014
- Mesenchymal Stem Cell Insights: Prospects in Cardiovascular TherapyCell Transplantation, 2014
- Cell therapy for cardiac repair—lessons from clinical trialsNature Reviews Cardiology, 2014
- Stem cell treatment for acute myocardial infarction2012
- Cardiac stem cell therapyHerz, 2011
- Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studiesThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells☆Cardiovascular Research, 2006
- Autologous bone-marrow stem-cell transplantation for myocardial regenerationThe Lancet, 2003
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997